254 related articles for article (PubMed ID: 24471777)
1. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.
von Keudell G; Sanchorawala V; O'Hara C; C Seldin D; Sloan JM
Amyloid; 2014 Jun; 21(2):124-7. PubMed ID: 24471777
[TBL] [Abstract][Full Text] [Related]
2. An unusual case of chronic lymphocytic leukemia, multiple myeloma and cardiac amyloidosis.
Liu D; Uqdah HT; Gordy AD
J Community Hosp Intern Med Perspect; 2017 Oct; 7(4):230-233. PubMed ID: 29046749
[TBL] [Abstract][Full Text] [Related]
3. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kourelis TV; Gertz M; Zent C; Lacy M; Kyle R; Kapoor P; Zeldenrust S; Buadi F; Witzig T; Hayman S; Lust J; Russell S; Lin Y; Rajkumar VS; Kumar S; Leung N; Dingli D; Dispenzieri A
Am J Hematol; 2013 May; 88(5):375-8. PubMed ID: 23508840
[TBL] [Abstract][Full Text] [Related]
4. A case of chronic lymphocytic leukemia associated with systemic light chain amyloidosis.
Wong E; Chew LP; Seymour JF
Leuk Lymphoma; 2013 Sep; 54(9):2062-4. PubMed ID: 23320887
[No Abstract] [Full Text] [Related]
5. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
6. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
[TBL] [Abstract][Full Text] [Related]
7. Biclonal chronic lymphocytic leukemia.
Hsi ED; Hoeltge G; Tubbs RR
Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
Ravindran A; Grogg KL; Domaas DA; Go RS
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):588-592. PubMed ID: 27600986
[No Abstract] [Full Text] [Related]
9. Immunoglobulin-related (AL) amyloidosis.
Husby G
Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
[TBL] [Abstract][Full Text] [Related]
10. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
11. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of cutaneous marginal zone lymphoma and cutaneous chronic lymphocytic leukemia.
Levin C; Mirzamani N; Zwerner J; Kim Y; Schwartz EJ; Sundram U
Am J Dermatopathol; 2012 Feb; 34(1):18-23. PubMed ID: 22257836
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody-encoding kappa L chain genes frequently rearranged in lambda L chain-expressing chronic lymphocytic leukemia.
Rassenti LZ; Pratt LF; Chen PP; Carson DA; Kipps TJ
J Immunol; 1991 Aug; 147(3):1060-6. PubMed ID: 1907304
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathologic analysis of light-chain (AL) amyloidosis in 7 patients].
Liu T; Hu A; Yuan H
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):260-1. PubMed ID: 24915818
[No Abstract] [Full Text] [Related]
15. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
16. The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype.
Aruga Y; Ikeda C; Matsushita H; Makita S; Fukuhara S; Munakata W; Izutsu K; Matsui H
Sci Rep; 2024 Jun; 14(1):13452. PubMed ID: 38862612
[TBL] [Abstract][Full Text] [Related]
17. Differences between κ and λ light chain amyloidosis analyzed by a pathologic scoring system.
Wu H; L'Imperio V; Rossi M; Kapp ME; Paueksakon P
Am J Clin Pathol; 2023 Aug; 160(2):144-149. PubMed ID: 36933186
[TBL] [Abstract][Full Text] [Related]
18. Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia.
van der Waal RI; van de Scheur MR; Huijgens PC; Starink TM; van der Waal I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Oct; 94(4):444-7. PubMed ID: 12374917
[TBL] [Abstract][Full Text] [Related]
19. Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature.
Ghodke KA; Patkar NV; Subramanian PG; Gujral S; Kadam PA; Tembhare PR
Indian J Pathol Microbiol; 2017; 60(1):84-86. PubMed ID: 28195098
[TBL] [Abstract][Full Text] [Related]
20. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
